Petspan requests that their press release NewsItemId: 20250708613679 issued July 08, 2025 “Petspan Launches First Telemedicine Protocol Using Rapamycin to Treat Hypertrophic Cardiomyopathy in Cats” be killed.

The release was issued prematurely by Petspan.

Our HCM protocol gives cat parents access to a therapy supported by peer-reviewed research demonstrating efficacy, pioneering the clinical application of rapamycin in veterinary cardiology while removing geographic barriers to this cutting-edge treatment.